Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
[google_news title=”” keyword=”Stroke treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stroke treatment
- American Stroke Association, Feb. 7-9on February 20, 2024 at 10:30 pm
International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 7 to 9 in Phoenix and drew participants from around the world, including ...
- Study highlights disparities in life-saving treatment for stroke after heart surgeryon February 19, 2024 at 11:33 am
Although stroke treatments have vastly improved in recent years, leading to better outcomes for many, one population of patients often does not receive these effective therapies: those who suffer ...
- Saving Brain Cells 8 to 9 Days After Strokeon February 19, 2024 at 7:08 am
Now, new medical research is giving patients hope that the damage done by strokes doesn't have to be permanent.
- PhilHealth increases stroke, dialysis packages in NorMinon February 19, 2024 at 5:14 am
The Philippine Health Insurance Corporation (PhilHealth) has expanded its health packages with additional centers in Northern Mindanao (NorMin). In a statement on Monday, PhilHealth Region 10 focal ...
- Greensboro woman shares her story to help other women fight and prevent heart disease and strokeon February 19, 2024 at 3:55 am
Emily Graham developed congestive heart failure and experienced a stroke due to the side-effects of radiation treatments of having breast cancer.
- Thrombectomy 'highly effective' long-term treatment after stroke, study sayson February 15, 2024 at 10:43 am
New research shows an endovascular thrombectomy helps create new connections around dead brain tissue after a stroke by restoring blood flow to damaged parts of the brain. The findings could improve ...
- Taking blood thinners after a stroke does not improve outcomes, study sayson February 15, 2024 at 2:00 am
Recent research suggests that adding blood thinners to clot-busting medication after an ischemic stroke may not be necessary, as it does not improve the 90-day outcome.
- Stroke survivors thank specialized ambulance, now dedicated to Colorado Springson February 14, 2024 at 4:42 pm
A new life-saving ambulance dedicated to emergency stroke care will now serve Colorado Springs full-time starting February 19.
- UCHealth unveils second Mobile Stroke Treatment Unit to serve Colorado Springson February 14, 2024 at 2:15 pm
Liz Wanersdorfer had a stroke at her home in Colorado Springs. Today, thanks to her husband’s quick thinking and the timely response of a mobile stroke treatment center, ...
- Men and Strokeon February 12, 2024 at 4:00 pm
Stroke is a medical emergency. Immediate treatment can save your life or increase your chances for a full recovery. The American Heart Association uses the memory tool known as F.A.S.T. to ...
via Bing News